SAN DIEGO–(BUSINESS WIRE)–CytoHub Inc., a biotechnology company utilizing the CardioVive AI-integrated human heart assembloid platform for drug safety and efficacy prediction, today announced that Scientific Co-Founder Aitor Aguirre, PhD, has been appointed to key leadership roles at the National Institutes of Health’s newly established Standardized Organoid Modeling (SOM) Center in Frederick, Maryland. Dr. Aguirre will serve as Director of the Tissue Engineering Laboratories at the Frederick
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
